Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Non-Final Rejection
The Status of Claims:
Claims 1-20 are pending.
Claims 1-16, and 19 are rejected.
Claims 14-18 and 20 are objected.
Claims 17-18 and 20 are withdrawn from consideration.
DETAILED ACTION
1. Claims 1-16, and 19 are under consideration in this Office Action.
Priority
2. It is noted that this application is a 371 of PCT/CN2022/078117 02/26/2022, , which has a foreign priority document, CHINA CN202110538115.6 05/18/2021.
.
Drawings
3. None.
IDS
4. The IDS filed on 11/03/23 are reviewed by the examiner.
Claim Objections
Claims 14-18 and 20 are objected to because of the following informalities:
In claims 14-15, there are various compounds listed in the claims; however, there are no commas among the compounds and there is also no expression of the term ”and “ before the last compound. Appropriate correction is required.
In claim 16, there is no period”.” at the end of the claim. Appropriate correction is required.
In claims 17-18 and 20, the expression “(Previously Presented)” is recited at the beginning of each of the claims. This expression is improper; this expression “(Previously Presented)” should be changed to “(Currently Withdrawn)” . Appropriate correction is required.
In the event the determination of the status of the application as subject to AIA 35
U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status.
Election/Restriction
Applicant’s election without traverse of Group I (claims 1-16, and 19 ) on 2/27/2026 is acknowledged. Claims 17-18 and 20 are withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to nonelected groups II, there being no allowable generic or linking claim.
The elected compound:
PNG
media_image1.png
120
241
media_image1.png
Greyscale
is allowable.
Claim Rejections - 35 USC § 112
The following is a quotation of 35 U.S.C. 112(b):
(b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention.
The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph:
The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention.
Claims 1-16, and 19 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor, or for pre-AIA the applicant regards as the invention.
In claim 1, the phrases “Ra, Rb, Rc, Rd and Re are independently selected from hydrogen, deuterium, halogen, substituted or unsubstituted C1-C1o alkyl, substituted or unsubstituted C3-C2ocycloalkyl, substituted or unsubstituted C6-C18 aryl, substituted or unsubstituted tri-C1-C1o alkyl silyl, substituted or unsubstituted tri-C6-C12 aryl silyl, or substituted or unsubstituted di-C1-Cio alkyl mono-C6-C3o aryl silyl” and “R1-R8 are independently selected from hydrogen, deuterium, halogen, hydroxyl, sulfhydryl, substituted or unsubstituted C1-Cio alkyl, substituted or unsubstituted C1-Cioheteroalkyl, substituted or unsubstituted C3-C2ocycloalkyl, substituted or unsubstituted C2-Cio alkenyl, substituted or unsubstituted C2-Cioalkynyl, substituted or unsubstituted C6-Cis aryl, substituted or unsubstituted C2-C17heteroaryl, substituted or unsubstituted tri-C1-Cio alkyl silyl, substituted or unsubstituted tri-C6-C12 aryl silyl, or substituted or unsubstituted di-C1-Cio alkyl mono- C6-C3o aryl silyl” are recited.
These expressions are improper because the Markush expression would require a close ended “and “ instead of an open ended “or” at the end. Appropriate correction is required.
The Close Prior Art
The close prio art to the current invention is Ma et al (US 2013/0181190 A1) A1), which discloses a generic iridium complex compound in the following:
PNG
media_image2.png
304
485
media_image2.png
Greyscale
.
However, this particular type of the generic iridium complex compound is chemical structurally different from the claimed iridium complex compound of Formula (I):
PNG
media_image3.png
400
814
media_image3.png
Greyscale
.
So, it would have been unobvious to the skilled artisan in the art over the claimed invention.
Conclusion
Any inquiry concerning this communication or earlier communications from the examiner should be directed to TAYLOR V OH whose telephone number is (571)272-0689. The examiner can normally be reached 8:00-5:00.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Andrew Kosar can be reached at 571-272-0913. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/TAYLOR V OH/Primary Examiner, Art Unit 1625 5/02/2026
Prosecution Insights